BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 1999
View Archived Issues
Company Profile: MetaXen
Read More
Ares-Serono: Annual Report 1998
Read More
Genzyme General highlights development plans at analysts meeting
Read More
AltaRex grants Purdue Pharma an option to license two AIT products
Read More
Xoma concludes patient enrollment in Neuprex phase III pivotal trial
Read More
News from ASCO: Lutrin is safe and effective in treating locally recurrent breast cancer
Read More
Synaptic and Warner-Lambert terminate galanin receptor research collaboration
Read More
New vitronectin receptor ligands for osteoporosis, etc., synthesized by HMR and Genentech
Read More
Cytokine-suppressive antiinflammatory agents in development at SmithKline Beecham
Read More
Sanofi reports preparation and use of new cholecystokinin agonists
Read More
Phospholamban inhibitors described by Orion for use in heart failure
Read More
Disappointing results from interim analysis of experimental lupus drug
Read More
Pharmacologically useful PTPase inhibitors developed by Ontogen and Novo Nordisk
Read More
Johnson & Johnson withdraws from norastemizole collaboration
Read More
Lilly synthesizes potent and selective 5-HT4 receptor antagonists or partial agonists
Read More
Rebeccamycin analogue NSC-655649 evaluated in adult and pediatric cancer patients
Read More
Merck's new carbapenems useful against methicillin-resistant staphylococci
Read More
Synthetic histone deacetylase inhibitor with potent antitumor effects developed in Japan
Read More
Imagent improves echocardiographic evaluation of the heart in phase III trials
Read More
U.S. university research team designs potent and selective inhibitors of PGGTase-I
Read More
Pharmacokinetics of AG-2034 examined in patients; results reported at ASCO meeting
Read More
ASCO highlights: interim phase I results reported for declopramide
Read More
Enbrel shows positive results in early, active RA
Read More
Orally active antimetabolite CS-682 well tolerated in patients with refractory solid tumors
Read More
Lilly's multitargeted antifolate a protagonist at ASCO
Read More
Agouron acquired by Warner-Lambert
Read More
Further details and timetable of Rhone-Poulenc and Hoechst merger announced
Read More
Sonata now available in Denmark and Sweden
Read More
World's smallest transdermal estradiol system launched in U.S.
Read More
Two phase I trials of GBC-590 reported at ASCO meeting
Read More